Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Publication stageIn Press Accepted Manuscript
Many argue that drug prices should better reflect investments for research and development, while guaranteeing a reasonable return on investment. Although this approach might seem fair, it raises several issues.
Concept and design: Annemans
Acquisition and date: Annemans
Drafting of the manuscript: Annemans
Analysis and interpretation of data: Annemans
Conflict of Interest Disclosures:
The author reported no conflicts of interest.
Funding/Support: The author received no financial support for this research.